Paper30848801
Using Machine Learning to Identify Heterogeneous Effects in Randomized Clinical Trials-Moving Beyond the Forest Plot and Into the Forest.
Goldstein BA and 1 other. JAMA Netw Open, 2019. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Using Machine Learning to Identify Heterogeneous Effects in Randomized Clinical Trials-Moving Beyond the Forest Plot and Into the Forest. Papers, record 30848801. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30848801
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Using Machine Learning to Identify Heterogeneous Effects in Randomized Clinical Trials-Moving Beyond the Forest Plot and Into the Forest.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Smoke | Major topic |
| Blood Pressure | |
| Forests | |
| Humans | |
| Machine Learning | |
| Randomized Controlled Trials as Topic |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 30848803 | Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial. | https://conductscience.org/library/papers/30848803 |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41754183 | Machine Learning to Tailor Intermittent Fasting for Blood Pressure Improvement. | Nutrients | 2026 | https://conductscience.org/library/papers/41754183 | PubMed |
| 37833568 | Machine learning and personalized nutrition: a promising liaison? | Eur J Clin Nutr | 2024 | https://conductscience.org/library/papers/37833568 | PubMed |
| 37311869 | Post hoc subgroup analysis and identification-learning more from existing data. | Eur J Clin Nutr | 2023 | https://conductscience.org/library/papers/37311869 | PubMed |
| 36923325 | Artificial Intelligence Applied to clinical trials: opportunities and challenges. | Health Technol (Berl) | 2023 | https://conductscience.org/library/papers/36923325 | PubMed |
| 34716669 | Heterogeneous treatment effect analysis based on machine-learning methodology. | CPT Pharmacometrics Syst Pharmacol | 2021 | https://conductscience.org/library/papers/34716669 | PubMed |
| 34295910 | Big Data, Data Science, and Causal Inference: A Primer for Clinicians. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34295910 | PubMed |
| 33626889 | Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy. | J Am Heart Assoc | 2021 | https://conductscience.org/library/papers/33626889 | PubMed |
| 32685596 | Machine Learning for Precision Health Economics and Outcomes Research (P-HEOR): Conceptual Review of Applications and Next Steps. | J Health Econ Outcomes Res | 2020 | https://conductscience.org/library/papers/32685596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30848801
GET https://conductscience.org/api/papers/v1/30848801/authors